Results 51 to 60 of about 226,558 (238)

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Need for oxygen.

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source

Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol

Systematic Reviews, 2021
Background Preterm birth (PTB) is estimated to affect 14.9 million babies globally every year. Global rates of PTB continue to increase from 9.8 to 10.6% over a 15-year period from 2000 to 2014.
Kimberley P. Williams, Liam McAuliffe, Rosanna Diacci, Anne-Marie Aubin, Ashad Issah, Carol Wang, Jason Phung, Craig E. Pennell   +7 more
doaj   +1 more source

Oral micronized progesterone combined with vaginal progesterone gel for luteal support

Gynecological Endocrinology, 2011
The aim of the present study was to compare the efficacy and satisfaction rate of combined therapy of oral micronized progesterone capsules and vaginal progesterone gel versus monotherapy with vaginal progesterone gel in luteal support. A case-control study was performed on a total number of 370 women aged
Vlatka, Tomic, Jozo, Tomic, Djurdja Zigmundovac, Klaic   +2 more
openaire   +2 more sources

Deep learning–based automated cervical length measurement improves spontaneous preterm birth risk stratification in women with a borderline short cervix (20–25 mm) at mid‐trimester: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study evaluates whether deep learning (DL)‐based automated cervical length (CL) measurement provides improved risk stratification for spontaneous preterm birth (PTB), compared with conventional CL measurement methods, in women with a borderline short cervix by conventional methods (CL 20–25 mm) on mid‐trimester ultrasound ...
Ju‐Hee Yoon, Suhra Kim, Yun Ji Jung, Joon Ho Lee, Ja‐Young Kwon, Young‐Han Kim, Hayan Kwon   +6 more
wiley   +1 more source

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Perinatal death.

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source

A multicenter analysis of 1364 elective/rescue cerclages in Brazil: Perinatal outcomes, complications, and the role of vaginal progesterone

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate perinatal outcomes in women undergoing cervical cerclage for prevention of preterm birth in Brazilian maternity hospitals. Methods This retrospective cohort study included 1364 women with singleton pregnancies who underwent elective or rescue cervical cerclage between December 2003 and November 2025.
Isabella C. Bragheto, Gabriela M. Pereira, Camila Mirandez, Marcelo Luis Nomura, Elton Carlos Ferreira, Rodolfo C. de Pacagnella, Evelyn Traina, Danilo B. Silva, Karayna Gil Fernandes, Julia Negro, Conrado M. Coutinho, Manuella R. Pereira, Janete Vettorazzi, Julia Hubner, Edson Vieira Cunha Filho, Ellen M. Arlindo, Aluana R. Parola, Pedro D. Correa, Renato Passini Junior, Renato T. Souza   +19 more
wiley   +1 more source

Pharmacokinetic Properties of Three Forms of Vaginal Progesterone Administered in Either Single Or Multiple Dose Regimen in Healthy Post-menopausal Chinese Women

Frontiers in Pharmacology, 2017
Objective: A generic vaginal progesterone gel has recently been developed in China. Little is known about its pharmacokinetic properties in Chinese subjects.
Jianzhong Shentu, Guolan Wu, Junchun Chen, Xingjiang Hu, Huili Zhou, Jian Liu, Duo Lv, Lihua Wu   +7 more
doaj   +1 more source

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto, Martha Gulati, Suvarna S. Khadilkar, Angela H. E. M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea R. Genazzani, Hema Divakar, Athena Poppas, on behalf of the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO)   +9 more
wiley   +1 more source

Longitudinal vaginal pH, serum estrogen and progesterone.

, 2016
Vaginal pH (A) was determined utilizing a sterile pH probe as described in Methods. Blood was drawn from the seven subjects shown in Fig 1. Serum levels of estrogen (B) and progesterone (C) were measured by ELISA.
Douglas Gilbert (562086), Thomas J. Hope (108657), Paria Mirmonsef (599784), Danijela Maric (641722), Alan L. Landay (231177), Anna L. Hotton (599785), Gregory T. Spear (351854), Casey J. Gioia (699825)   +7 more
core   +1 more source

Forest plot comparison (Vaginal P compared with no treatment or placebo) for outcome: Birth weight.

, 2023
CI, confidence interval; Vaginal P, vaginal progesterone; SD, Standard deviation. (TIF)
Silvia Minozzi (5914076), Francesca Ferrari (5018804), Laura Basile (14664703), Fabio Facchinetti (3166995), Giuseppe Chiossi (5432516)   +4 more
core   +1 more source